An explorative intervention study to investigate the feasibility and safety of oral immunotherapy with different allergens in young children diagnosed with food allergy.

Deventer Ziekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•Children with an age of 9 to 24 months.
•A proven food allergy (positive provocation and sensitization demonstrated by a skin prick test > 3mm and / or slgÉ> 0.35kU / L) for chicken egg, peanut, cashew nut, hazelnut and / or wheat.
•Assessment of the presence of other food allergies (Standard care) by introduction in the diet and / or the determination of sensitization. From the mentioned allergens. Introduction into the diet or the diagnosis food
•allergy has been made.
•Written permission (signed informed consent form) from both parents / guardian for participation in the study.

•Uncontrolled viral wheezing, defined as admitted to hospital > 1x in the past six months because of these complaints.
•Uncontrolled eczema.
•Severe gastrointestinal complaints such as gastroesophageal reflux disease, where an underlying disease such as eosinophilic esophagitis (EoE) cannot be excluded.
•Active EoE.
•Mastocytosis (also cutaneous).
•Psycho-social problems in the family that may be a barrier to a good daily performance of long-term therapy.
•Inability of parents to follow instructions, to recognize allergic reactions or to administer emergency medication.
•Participation in any other intervention study at the time of the ORKA study, with the exception of studies on guided early introduction of high-allergenic nutrition.

发起方